|
Aug 6
|
Nxera debuts an obesity pipeline; BridgeBio battles Alnylam for market share
|
|
Aug 5
|
Alnylam to Webcast Presentation at Canaccord Genuity 45th Annual Growth Conference
|
|
Aug 5
|
Analyst Forecasts For Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Are Surging Higher
|
|
Aug 4
|
Sector Update: Health Care Stocks Advance Monday Afternoon
|
|
Aug 4
|
Earnings Estimates Rising for Alnylam (ALNY): Will It Gain?
|
|
Aug 4
|
Alnylam's Amvuttra Sales Exceeding Expectations by Sizable Margin, Oppenheimer Says
|
|
Aug 4
|
Coinbase downgraded, Spotify upgraded: Wall Street's top analyst calls
|
|
Aug 2
|
Alnylam Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 1
|
Alnylam's Amvuttra Makes Powerful Entrance, Eyes First-Line Dominance
|
|
Aug 1
|
ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up
|
|
Aug 1
|
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Has Found A Path To Profitability
|
|
Jul 31
|
Alnylam (ALNY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Jul 31
|
Alnylam reaches new highs on strong sales of closely watched rare disease drug
|
|
Jul 31
|
Alnylam Pharmaceuticals (ALNY) Q2 Earnings and Revenues Beat Estimates
|
|
Jul 31
|
Alnylam: Q2 Earnings Snapshot
|
|
Jul 31
|
Alnylam Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Period Progress
|
|
Jul 28
|
High Growth Tech Stocks In The US To Watch This July 2025
|
|
Jul 26
|
Alnylam Pharmaceuticals, Inc. (ALNY) Gets EU Nod for AMVUTTRA
|
|
Jul 25
|
High Growth Tech Stocks to Watch in the US July 2025
|
|
Jul 25
|
Exploring High Growth Tech Stocks in the US This July 2025
|